Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin and TMPS for Malaria and STI Prevention in Pregnant Women With HIV
NCT03431168Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Mar 2018
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of azithromycin in malaria and sexually transmitted infection (STI), sponsored by University of Alabama at Birmingham. Primary endpoint: Plasmodium Falciparum Peripheral Parasitemia. Started Mar 2018; status: completed.
02
Drugs
azithromycin
03
Conditions
malariasexually transmitted infection (STI)
Beyond the preview
Go deeper on NCT03431168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03431168.